|
Volumn 81, Issue 2, 1997, Pages 533-553
|
Human immunodeficiency virus infection in women
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIRETROVIRUS AGENT;
ANTIVIRUS AGENT;
BETAMETHASONE DIPROPIONATE;
CEFTRIAXONE;
DOXYCYCLINE;
ESTROGEN;
FLUCONAZOLE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN;
KETOCONAZOLE;
LAMIVUDINE;
MEGESTROL ACETATE;
METRONIDAZOLE;
MONOCLONAL ANTIBODY;
MYCOLOG;
TESTOSTERONE;
ZIDOVUDINE;
ZINC OXIDE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GENITAL HERPES;
GYNECOLOGIC DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVAGINAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
META ANALYSIS;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PELVIC INFLAMMATORY DISEASE;
PREGNANCY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TRICHOMONIASIS;
UNITED STATES;
UTERINE CERVICITIS;
UTERINE CERVIX CARCINOMA IN SITU;
VAGINA ATROPHY;
VAGINA CANDIDIASIS;
VAGINITIS;
|
EID: 0030998085
PISSN: 00257125
EISSN: None
Source Type: Journal
DOI: 10.1016/S0025-7125(05)70530-7 Document Type: Article |
Times cited : (9)
|
References (100)
|